Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer

NCT04906395 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: TOL2506
DRUG: Tamoxifen
DRUG: Letrozole Tablets
DRUG: Anastrozole Tablets
DRUG: Exemestane Tablets

Sponsor

Tolmar Inc.